Literature DB >> 2661433

Pathogenesis of weight-related changes in blood pressure in dogs.

A P Rocchini1, C P Moorehead, S DeRemer, D Bondie.   

Abstract

We have previously shown that weight gain in the dog results in an increase in blood pressure. To study the pathogenesis of the rise in blood pressure associated with weight gain, we compared the serial changes in blood pressure, body weight, sodium balance, plasma volume, and three hormones known to affect sodium balance (norepinephrine, insulin, and aldosterone) in seven dogs fed a high fat diet for 6 weeks and seven dogs fed a control diet. The sodium content of both diets was equal. During a 2-week control period, no differences were noted between the two groups. Weight gain was associated with a progressive increase in blood pressure (mean pressure increased by 18.5 +/- 2.1 mm Hg in the high fat group) and plasma volume (plasma volume increased from 1,426 +/- 202 to 2,053 +/- 250 ml in the high fat group). Sodium retention occurred after 1 week of the high fat diet and persisted. Over the 6-week period, the dogs on the high fat diet increased their cumulative sodium balance by 2,024 +/- 462 meq versus an increase of only 289 +/- 97 meq for the dogs on the control diet. In the high fat diet group of dogs, there was a significant relation between change in cumulative sodium balance and the change in blood pressure and plasma volume. After 1 week of the high fat diet, norepinephrine was the only hormone that significantly increased from baseline. Over the next 5 weeks norepinephrine increased no further, whereas fasting insulin and aldosterone progressively increased.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2661433     DOI: 10.1161/01.hyp.13.6.922

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  12 in total

Review 1.  Nonesterified fatty acids in blood pressure control and cardiovascular complications.

Authors:  B M Egan; E L Greene; T L Goodfriend
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 2.  The renin-angiotensin-aldosterone system and glucose homeostasis.

Authors:  James Matthew Luther; Nancy J Brown
Journal:  Trends Pharmacol Sci       Date:  2011-08-29       Impact factor: 14.819

3.  Differences in blood volume components between hyporesponders and responders to erythropoietin alfa: the heart failure with preserved ejection fraction (HFPEF) anemia trial.

Authors:  Margarita Borovka; Sergio Teruya; Julissa Alvarez; Stephen Helmke; Mathew S Maurer
Journal:  J Card Fail       Date:  2013-10       Impact factor: 5.712

Review 4.  Cardiovascular and sympathetic effects of leptin.

Authors:  Kamal Rahmouni; William G Haynes; Allyn L Mark
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

5.  Obesity-hypertension and its relation to other diseases in dogs.

Authors:  Alicia Pamela Pérez-Sánchez; Javier Del-Angel-Caraza; Israel Alejandro Quijano-Hernández; Marco Antonio Barbosa-Mireles
Journal:  Vet Res Commun       Date:  2015-02-10       Impact factor: 2.459

6.  Systemic and renal-specific sympathoinhibition in obesity hypertension.

Authors:  Thomas E Lohmeier; Radu Iliescu; Boshen Liu; Jeffrey R Henegar; Christine Maric-Bilkan; Eric D Irwin
Journal:  Hypertension       Date:  2011-12-19       Impact factor: 10.190

7.  Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study.

Authors:  Maria Baltazi; Niki Katsiki; Christos Savopoulos; Fotios Iliadis; George Koliakos; Apostolos I Hatzitolios
Journal:  Am J Cardiovasc Dis       Date:  2011-05-20

Review 8.  Neural mechanisms and management of obesity-related hypertension.

Authors:  Murray D Esler; Nina Eikelis; Elisabeth Lambert; Nora Straznicky
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

Review 9.  Epidemiology of high blood pressure and obesity.

Authors:  F J Martínez; J M Sancho-Rof
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 10.  Molecular Mechanisms of Sodium-Sensitive Hypertension in the Metabolic Syndrome.

Authors:  Jonathan M Nizar; Vivek Bhalla
Journal:  Curr Hypertens Rep       Date:  2017-08       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.